We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Inspire (INSP) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
Wall Street analysts forecast that Inspire Medical Systems (INSP - Free Report) will report quarterly earnings of $0.69 per share in its upcoming release, pointing to a year-over-year decline of 40%. It is anticipated that revenues will amount to $269 million, exhibiting an increase of 12.2% compared to the year-ago quarter.
Over the last 30 days, there has been a downward revision of 28.6% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some Inspire metrics that Wall Street analysts commonly model and monitor.
The collective assessment of analysts points to an estimated 'Geographic Revenue- United States' of $255.18 million. The estimate points to a change of +10.2% from the year-ago quarter.
The consensus estimate for 'Geographic Revenue- All other countries' stands at $10.63 million. The estimate indicates a year-over-year change of +31.5%.
It is projected by analysts that the 'Total U.S. sales territories' will reach 342 . Compared to the current estimate, the company reported 335 in the same quarter of the previous year.
Over the past month, Inspire shares have recorded returns of -31.6% versus the Zacks S&P 500 composite's no change. Based on its Zacks Rank #3 (Hold), INSP will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Inspire (INSP) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Wall Street analysts forecast that Inspire Medical Systems (INSP - Free Report) will report quarterly earnings of $0.69 per share in its upcoming release, pointing to a year-over-year decline of 40%. It is anticipated that revenues will amount to $269 million, exhibiting an increase of 12.2% compared to the year-ago quarter.
Over the last 30 days, there has been a downward revision of 28.6% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some Inspire metrics that Wall Street analysts commonly model and monitor.
The collective assessment of analysts points to an estimated 'Geographic Revenue- United States' of $255.18 million. The estimate points to a change of +10.2% from the year-ago quarter.
The consensus estimate for 'Geographic Revenue- All other countries' stands at $10.63 million. The estimate indicates a year-over-year change of +31.5%.
It is projected by analysts that the 'Total U.S. sales territories' will reach 342 . Compared to the current estimate, the company reported 335 in the same quarter of the previous year.
View all Key Company Metrics for Inspire here>>>Over the past month, Inspire shares have recorded returns of -31.6% versus the Zacks S&P 500 composite's no change. Based on its Zacks Rank #3 (Hold), INSP will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .